These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37193675)

  • 1. Turning the Spotlight on Apathy: Identification and Treatment in Schizophrenia Spectrum Disorders.
    Lyngstad SH; Lyne JP; Ihler HM; van der Meer L; Færden A; Melle I
    Schizophr Bull; 2023 Sep; 49(5):1099-1104. PubMed ID: 37193675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The clinic of apathy in schizophrenia: a critical review of the issue].
    Yazbek H; Raffard S; Del-Monte J; Pupier F; Larue A; Boulenger JP; Gély-Nargeot MC; Capdevielle D
    Encephale; 2014 Jun; 40(3):231-9. PubMed ID: 23958346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurophysiological correlates of Avolition-apathy in schizophrenia: A resting-EEG microstates study.
    Giordano GM; Koenig T; Mucci A; Vignapiano A; Amodio A; Di Lorenzo G; Siracusano A; Bellomo A; Altamura M; Monteleone P; Pompili M; Galderisi S; Maj M;
    Neuroimage Clin; 2018; 20():627-636. PubMed ID: 30202724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Individual negative symptoms and domains - Relevance for assessment, pathomechanisms and treatment.
    Kaiser S; Lyne J; Agartz I; Clarke M; Mørch-Johnsen L; Faerden A
    Schizophr Res; 2017 Aug; 186():39-45. PubMed ID: 27453425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiology of negative symptom dimensions of schizophrenia - Current developments and implications for treatment.
    Bègue I; Kaiser S; Kirschner M
    Neurosci Biobehav Rev; 2020 Sep; 116():74-88. PubMed ID: 32533996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving Pleasure and Motivation in Schizophrenia: A Randomized Controlled Clinical Trial.
    Favrod J; Nguyen A; Chaix J; Pellet J; Frobert L; Fankhauser C; Ismailaj A; Brana A; Tamic G; Suter C; Rexhaj S; Golay P; Bonsack C
    Psychother Psychosom; 2019; 88(2):84-95. PubMed ID: 30783071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recognizing primary vs secondary negative symptoms and apathy vs expression domains.
    Kirkpatrick B
    J Clin Psychiatry; 2014 Apr; 75(4):e09. PubMed ID: 24813410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative symptom dimensions in first episode psychosis: Is there a difference between schizophrenia and non-schizophrenia spectrum disorders?
    Pelizza L; Azzali S; Paterlini F; Garlassi S; Scazza I; Chiri LR; Poletti M; Pupo S; Raballo A
    Early Interv Psychiatry; 2021 Dec; 15(6):1513-1521. PubMed ID: 33238327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Negative symptom configuration within and outside schizophrenia spectrum disorders: results from the "Parma Early Psychosis" program.
    Pelizza L; Maestri D; Leuci E; Quattrone E; Azzali S; Paulillo G; Pellegrini P
    Psychiatry Res; 2020 Dec; 294():113519. PubMed ID: 33130513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive Emotions Program for Schizophrenia (PEPS): a pilot intervention to reduce anhedonia and apathy.
    Favrod J; Nguyen A; Fankhauser C; Ismailaj A; Hasler JD; Ringuet A; Rexhaj S; Bonsack C
    BMC Psychiatry; 2015 Sep; 15():231. PubMed ID: 26419356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amotivation and functional outcomes in early schizophrenia.
    Fervaha G; Foussias G; Agid O; Remington G
    Psychiatry Res; 2013 Dec; 210(2):665-8. PubMed ID: 23911005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between resilience and psychosocial functioning in schizophrenia: A systematic review and meta-analysis.
    Wambua GN; Kilian S; Ntlantsana V; Chiliza B
    Psychiatry Res; 2020 Nov; 293():113374. PubMed ID: 32795771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An active inference perspective on the negative symptoms of schizophrenia.
    Jeganathan J; Breakspear M
    Lancet Psychiatry; 2021 Aug; 8(8):732-738. PubMed ID: 33865502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring motivation in people with schizophrenia.
    Fervaha G; Foussias G; Takeuchi H; Agid O; Remington G
    Schizophr Res; 2015 Dec; 169(1-3):423-426. PubMed ID: 26391283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Negative Symptoms in Schizophrenia - an Overview].
    Klaus F; Kaiser S; Kirschner M
    Ther Umsch; 2018 Jun; 75(1):51-56. PubMed ID: 29909762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metamotivation in people diagnosed with schizophrenia: A conceptual introduction and qualitative study.
    Hansen MC; Lynch DA; Stefancic A; Medalia A
    Schizophr Res; 2022 May; 243():317-321. PubMed ID: 34325963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of primary negative symptoms on functional outcomes in schizophrenia.
    Fervaha G; Foussias G; Agid O; Remington G
    Eur Psychiatry; 2014 Sep; 29(7):449-55. PubMed ID: 24630742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized trial to evaluate the efficacy of cognitive therapy for low-functioning patients with schizophrenia.
    Grant PM; Huh GA; Perivoliotis D; Stolar NM; Beck AT
    Arch Gen Psychiatry; 2012 Feb; 69(2):121-7. PubMed ID: 21969420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [History and current state of the problem of negative disorders (research of nosological period)].
    Smulevich AB; Lobanova VM; Voronova EI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(2):122-130. PubMed ID: 33728861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing apathy: the use of the Apathy Evaluation Scale in first episode psychosis.
    Faerden A; Nesvåg R; Barrett EA; Agartz I; Finset A; Friis S; Rossberg JI; Melle I
    Eur Psychiatry; 2008 Jan; 23(1):33-9. PubMed ID: 18029152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.